# Ashland Radiation Oncology PSC – FDA Inspection, May 29, 2014

Source: https://www.keypedia.com/records/fda_inspections/ashland-radiation-oncology-psc/4af24296-cd77-474d-b274-a7283b989e6d
Source feed: FDA_Inspections

> FDA inspection 880821 of Ashland Radiation Oncology PSC, May 29, 2014. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 880821
- Company Name: Ashland Radiation Oncology PSC
- Inspection Date: 2014-05-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1271777 - 2025-06-02
- FDA Inspection 1064926 - 2018-08-28
- FDA Inspection 980307 - 2016-08-09
- [FDA Inspection 779664 - 2012-04-02](https://www.keypedia.com/records/fda_inspections/ashland-radiation-oncology-psc/57d838fa-23ce-4dcd-8c4a-46f8ea8d91ce)
- [FDA Inspection 680883 - 2010-07-08](https://www.keypedia.com/records/fda_inspections/ashland-radiation-oncology-psc/d97081a0-97dd-42ff-8ec2-c0d7d13976bf)

Company: https://www.keypedia.com/companies/ashland-radiation-oncology-psc/f25b2642-1880-4369-b956-6b56c1743916

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d